Micropharm Limited
Manufacture of basic pharmaceutical products · Newcastle Emlyn
ActiveUnited KingdomIncorporated 1998Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2019-03-31
IXBRL · 234 source facts · 24 selected values
Not assessedlegacy record
Accounts to 2019-03-31
IXBRL · 234 source facts · 24 selected values
Not assessed
legacy record
- Reporting period
- 2018-04-01 to 2019-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 166
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0073_03617656_20190331
- Source archive
- Accounts_Monthly_Data-December2019.zip
Accounts to 2018-03-31
IXBRL · 237 source facts · 24 selected values
Not assessedlegacy record
Accounts to 2018-03-31
IXBRL · 237 source facts · 24 selected values
Not assessed
legacy record
- Reporting period
- 2017-04-01 to 2018-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 171
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0061_03617656_20180331
- Source archive
- Accounts_Monthly_Data-December2018.zip
Accounts to 2017-03-31
IXBRL · 150 source facts · 19 selected values
Not assessedlegacy record
Accounts to 2017-03-31
IXBRL · 150 source facts · 19 selected values
Not assessed
legacy record
- Reporting period
- 2016-04-01 to 2017-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 87
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0049_03617656_20170331
- Source archive
- Accounts_Monthly_Data-December2017.zip
Accounts to 2015-03-31
IXBRL · 112 source facts · 20 selected values
Not assessedlegacy record
Accounts to 2015-03-31
IXBRL · 112 source facts · 20 selected values
Not assessed
legacy record
- Reporting period
- 2013-10-01 to 2015-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 56
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0020_03617656_20150331
- Source archive
- Accounts_Monthly_Data-July2015.zip
Accounts to 2013-09-30
IXBRL · 115 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2013-09-30
IXBRL · 115 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2012-10-01 to 2013-09-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 60
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0004_03617656_20130930
- Source archive
- Accounts_Monthly_Data-March2014.zip
Registered details
03617656- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 1998-08-18
- Jurisdiction
- —
- Registered office
- UNITS F & G, STATION ROAD INDUSTRIAL ESTATE, NEWCASTLE EMLYN, CARMARTHENSHIRE, SA38 9BY, UNITED KINGDOM
Classification
1 SIC codes21100
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
1 SH01-derived rounds2026-03-25
£15,775,817 raised
£25,879,430 estimated post-money
Research and innovation
2 matched grantsPreclinical development and assessment of an oral therapeutic for Clostridium difficile infectionLeadInnovate UK · Collaborative R&D · 2017-02-01 – 2018-07-31 · with 2 other participants£195,567awarded
Preclinical development and assessment of an oral therapeutic for Clostridium difficile infectionLead
Innovate UK · Collaborative R&D · 2017-02-01 – 2018-07-31 · with 2 other participants
£195,567
awarded
Micropharm Limitedlead£195,567
Public Health England (Health Protection Agency)£128,249
Use of Ovine Polyclonal Antibodies to Treat Severe Clostridium difficile InfectionsLeadInnovate UK · Collaborative R&D · 2013-11-01 – 2016-10-31 · with 2 other participants£787,152awarded
Use of Ovine Polyclonal Antibodies to Treat Severe Clostridium difficile InfectionsLead
Innovate UK · Collaborative R&D · 2013-11-01 – 2016-10-31 · with 2 other participants
£787,152
awarded
Micropharm Limitedlead£787,152
Public Health England (Health Protection Agency)£751,153